866G/A and Ins/Del polymorphisms in UCP2 gene are associated with reduced short-term weight loss in patients who underwent Roux-en-Y gastric bypass

2021 ◽  
Author(s):  
Mayara S. de Oliveira ◽  
Michelle Rodrigues ◽  
Elis A. Rossoni ◽  
Denise A. Sortica ◽  
Jakeline Rheinheimer ◽  
...  
Keyword(s):  
Weight Loss ◽  
Gastric Bypass ◽  
Short Term ◽  
Ucp2 Gene

Short-Term Results of Single-Anastomosis Gastric Bypass After Failed Sleeve Gastrectomy

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Alaa Abbas Sabry ◽  
Karim Sabry Abd-Elsamee ◽  
Mohamed Ibrahim Mohamed ◽  
Mohammed Mohamed Ahmed Abd-Elsalam
Keyword(s):  
Weight Loss ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Weight Regain ◽  
Revisional Surgery ◽  
One Anastomosis Gastric Bypass ◽  
Short Term ◽  
Multicenter Studies ◽  
Metabolic Outcomes

Abstract Background It is already known that Laparoscopic sleeve gastrectomy (LSG) has gained popularity as a stand-alone procedure with good short-term results for weight loss. However, in the long-term, weight regain is considered as a complication. Demand for secondary surgery is rising, partly for this reason, but through that study we try to discover the efficacy of conversion of failed sleeve gastrectomy to one anastomosis gastric bypass (OAGB) regarding weight loss and metabolic outcomes. Objective To asses the efficacy and safety of one anastomosis gastric bypass (OAGB) as a conversion surgery post Sleeve Gastrectomy failure as regard weight loss and metabolic outcomes. Patients and Methods This study is a retrospective cohort study which included 20 patients underwent one anastomosis gastric bypass at Ain-Shams University El-Demerdash Hospital, Cairo, Egypt and specialized bariatric center, Cairo, Egypt From February 2019 to July 2019 with 6 months of postoperative follow up till January 2019. Results In this study, we reviewed and analyzed the outcomes from the revision of the SG due to either inadequate weight loss or weight regain to one anastomosis gastric bypass (OAGB) with %EBWL of 6.65% at 1 month, 13.61 % at 3 months and 20.86% at 6 months. Conclusion OAGB appears to be an effective and safe therapeutic technique as a revisional surgery for failed primary SG with good short-term results for treating morbid obesity and its associated comorbidities with a significantly low rate of complications. However the EBWL was less than what is reported after primary OAGB weight. Multicenter studies with larger series of patients and longer term follow up after SG revisions to OAGB are warranted.

scholarly journals Postoperative continuation of antidepressant therapy is associated with reduced short-term weight loss following Roux-en-Y gastric bypass surgery

2019 ◽  
Vol 404 (5) ◽  
pp. 621-631 ◽  
Author(s):  
Philip Plaeke ◽  
Filip Van Den Eede ◽  
Ben Gys ◽  
Anthony Beunis ◽  
Martin Ruppert ◽  
...  
Keyword(s):  
Weight Loss ◽  
Gastric Bypass ◽  
Bypass Surgery ◽  
Gastric Bypass Surgery ◽  
Antidepressant Therapy ◽  
Short Term

The Ala55Val and -866G>A polymorphisms of the UCP2 gene could be biomarkers for weight loss in patients who had Roux-en-Y gastric bypass

Nutrition ◽  
2017 ◽  
Vol 33 ◽  
pp. 326-330 ◽  
Author(s):  
Carolina F. Nicoletti ◽  
Ana Paula R.P. de Oliveira ◽  
Maria José F. Brochado ◽  
Marcela A.S. Pinhel ◽  
Bruno A.P. de Oliveira ◽  
...  
Keyword(s):  
Weight Loss ◽  
Gastric Bypass ◽  
Ucp2 Gene

scholarly journals Does Preoperative Weight Change Predict Postoperative Weight Loss after Laparoscopic Roux-en-Y Gastric Bypass in the Short Term?

2010 ◽  
Vol 2010 ◽  
pp. 1-4 ◽  
Author(s):  
Dan Eisenberg ◽  
Andrew J. Duffy ◽  
Robert L. Bell
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Gastric Bypass ◽  
Weight Change ◽  
Regression Analyses ◽  
Short Term ◽  
Postoperative Weight Loss ◽  
Significant Difference ◽  
Preoperative Weight ◽  
One Way Anova

Background. Many institutions mandate preoperative weight loss prior to bariatric surgery. This study examines the correlation between preoperative weight change and postoperative success following laparoscopic Roux-en-Y gastric bypass.Methods. We retrospectively studied the correlation between change in BMI before surgery and change in BMI postoperatively, using linear regression analyses and one-way ANOVA, in 256 consecutive gastric bypass patients with 1-year followup.Results. Of 256 patients, 125 lost weight preoperatively (mean % BMI), while 131 maintained or gained weight (mean +1.2% BMI). Postoperatively, there was no significant difference in percent BMI loss between the two groups (34.6% and 34.5%). The percent change in BMI preoperatively did not predict postoperative BMI change after 1 year ().Conclusions. Our study did not show any correlation between preoperative weight change and postoperative weight loss after Roux-en-Y gastric bypass. Therefore, we do not believe that potential patients should be denied bariatric surgery on the basis of their inability to lose weight preoperatively.

Roux-en-y gastric bypass improves in short term the clinical-anthropometric parameters and reduces risk for obesity-related cardiometabolic diseases / Bypass gástrico roux-en-y melhora a curto prazo os parâmetros clínico-antropométricos e reduz o risco de doenças cardiometabólicas relacionadas à obesidade

2021 ◽  
Vol 7 (7) ◽  
pp. 73573-73587
Author(s):  
Thiago da Rosa Lima ◽  
Paula Caroline De Almeida ◽  
Fabrício Azevedo Voltarelli ◽  
Lilian Culturato ◽  
Eudes Thiago Pereira Ávila ◽  
...  
Keyword(s):  
Risk Factors ◽  
Weight Loss ◽  
Gastric Bypass ◽  
Abdominal Circumference ◽  
Short Term ◽  
Anthropometric Parameters ◽  
Significance Level ◽  
Cardiometabolic Diseases ◽  
Abdominal Perimeter ◽  
Before And After

Roux-en-Y gastric bypass surgery (RYGB) is the most applied technique in the treatment of severe obesity worldwide. However, its impact on anthropometric parameters and the risk for cardiometabolic diseases in obese patients is uncertain. To evaluate anthropometric clinical parameters and the evolution of risk factors for obesity-related diseases in individuals of both sexes undergoing RYGB. Sixty-nine adults subjects from both sexes submitted to RYGB surgery treatment were divided into 3 groups: G1(13 months, n=24); G2 (13 and 25 months, n=21), and G3 (25 and 37 months, n=24). Sociodemographic and anthropometric information before and after surgery were collected. The abdominal perimeter was used in the classification of cardiometabolic risk and the BMI was used for the risk of obesity-related diseases. Hypotheses were tested by Student's t-test and ANOVA, and the significance level adopted was 5%. The average age was 36.0±10.0 years, with 69.6% being male and 30.4% female. Anthropometric parameters (weight, BMI, and abdominal circumference) were higher among women, except for weight loss and percentage of weight loss. There was a difference in weight loss between the sexes in the moments before and after RYGB. There was a decrease in the risk of disease due to obesity and cardiovascular diseases after RYGB. Weight loss and %WL were greater years by year in the short term of 3 years after surgery. RYGB proved to be an effective strategy for both sexes in combating obesity, providing in the short term a significant improvement in clinical-anthropometric parameters and reduction of risk factors for obesity-related cardiometabolic diseases.

Sign in / Sign up

Export Citation Format

Share Document